People · Operator

Sarah O'Connor

Named in public records as an officer, director or promoter · active 2014–2017 · Other Health Care

2
Companies
4
Filings
$92.6M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Quotient LtdOther Health CareSeries C$92.2M$918.1M2014
Sadiant LLCOther Health CarePre-Seed$415K$12.8M2016
Operator network

Sarah O'Connor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Zubeen Shroff · 5 companies · 1 sharedZubeen ShroffBrian McDonough · 1 companies · 1 sharedBrian McDonoughChristopher Lindop · 1 companies · 1 sharedChristopher LindopEdward Farrell · 1 companies · 1 sharedEdward FarrellFrederick Hallsworth · 1 companies · 1 sharedFrederick Hallswo…Heino Von Prondzynski · 1 companies · 1 sharedHeino Von Prondzy…Jeremy Stackawitz · 1 companies · 1 sharedJeremy StackawitzJohn Wilkerson · 1 companies · 1 sharedJohn WilkersonPaul Cowan · 1 companies · 1 sharedPaul CowanRoland Boyd · 1 companies · 1 sharedRoland BoydStephen Unger · 1 companies · 1 sharedStephen UngerThomas Bologna · 1 companies · 1 sharedThomas BolognaJon Kurth · 1 companies · 1 sharedJon KurthQuotient Ltd · $92.2M raisedQuotient LtdSadiant LLC · $0.4M raisedSadiant LLCSarah O'ConnorSO
Sarah O'Connor Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Sarah O'Connor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Zubeen Shroff15
Frederick Hallsworth11
Roland Boyd11
Stephen Unger11
Heino Von Prondzynski11
Brian McDonough11
Paul Cowan11
Thomas Bologna11
Jeremy Stackawitz11
John Wilkerson11
Edward Farrell11
Christopher Lindop11
Jon Kurth11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.